Association of Medicine and Psychiatry Annual Meeting 2003
Loews Coronado Bay Resort, Coronado, San Diego, CA November 19, 2003 Program Director: Ted Stern MD Massachusetts General Hospital Theme: The Interface of Medicine and Psychiatry: A Closer Look at Neurocardiology
Posted by Rick_Malison 2003/4/15 21:50:24 (2785 reads)
Primary Care Companion J Clin Psychiatry 2002;4:224-231
Evaluating the Impact of an Educational Program on Practice Patterns of Canadian Family Physicians Interested in Depression Treatment
Stanley Paul Kutcher, M.D., F.R.C.P.C.; Bianca Aurora Lauria-Horner, M.D.; Connie Marian MacLaren, B.Sc.N., M.H.S.A.; and Maja Bujas-Bobanovic, M.D., M.Sc.
Background: Depression is frequently unrecognized and undertreated. Therefore, there is a need to increase the knowledge and skills of primary care physicians regarding the diagnosis and treatment of depression. The aim of this study was to provide, and evaluate the impact of, a brief educational program with a number of practice tools and resources in order to improve family physicians' knowledge, diagnosis, and treatment of depression.
Posted by Rick_Malison 2003/4/15 21:47:30 (2661 reads)
Primary Care Companion J Clin Psychiatry 2002;4:215-223
Celebrity Patients, VIPs, and Potentates
James E. Groves, M.D.; Barbara A. Dunderdale, R.N., M.B.A.; and Theodore A. Stern, M.D.
Background: During the second half of the 20th century, the literature on the doctor-patient relationship mainly dealt with the management of "difficult" (personality-disordered) patients. Similar problems, however, surround other types of "special" patients.
Posted by Rick_Malison 2003/4/15 21:46:06 (2635 reads)
Primary Care Companion J Clin Psychiatry 2002;4:209-214
Escitalopram: A New SSRI for the Treatment of Depression in Primary Care
Larry Culpepper, M.D., M.P.H.
Escitalopram is the S-enantiomer of the racemic compound citalopram, a selective serotonin reuptake inhibitor (SSRI) widely used for the treatment of depression. This review describes the current body of pharmacologic and clinical evidence supporting the use of escitalopram for the treatment of depression and anxiety.
Posted by Rick_Malison 2003/2/18 20:22:58 (2352 reads)
Primary Care Companion J Clin Psychiatry 2002;4:191-195
The Feasibility of Using the Spanish PHQ-9 to Screen for Depression in Primary Care in Honduras
Lawson Wulsin, M.D.; Eugene Somoza, M.D.; and Jeffery Heck, M.D.
Background: The Patient Health Questionnaire depression module (PHQ-9) is a brief (10 items) screening and monitoring measure designed for use in primary care settings that operationalizes most of the DSM-IV and ICD-9 diagnostic criteria for major depression. In the United States, the PHQ-9 has become the recommended depression measure in primary care settings. However, there are no published reports of its use in developing countries and no reports of the feasibility of using the Spanish version of the PHQ-9 to screen for depression.
Posted by Rick_Malison 2003/2/18 20:20:34 (1935 reads)
Primary Care Companion J Clin Psychiatry 2002;4:184-190
On the Edge of Life, II: House Officer Struggles Recorded in an Intensive Care Unit Journal
Mikkael A. Sekeres, M.D., M.S., and Theodore A. Stern, M.D.
Background: In a general hospital, few clinical settings match the intensity of the intensive care unit (ICU) experience. Clinical rotations in ICUs elicit and emphasize the struggles house officers face on a daily basis throughout their training.
